NDC 63323-010-01 - Gentamicin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-010
- Requested NDC
- 63323-010-01
- Package NDCs from labels
- 63323-010-96, 63323-010-41, 63323-010-94, 63323-010-42, 63323-010-95, 63323-010-01, 63323-010-02, 63323-010-03, 63323-010-20
- Manufacturer
- Henry Schein, Inc
- Effective date
- 2025-10-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gentamicin - Henry Schein, Inc | Henry Schein, Inc | 2025-10-31 | HUMAN PRESCRIPTION DRUG LABEL |
| Gentamicin - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2024-10-11 | HUMAN PRESCRIPTION DRUG LABEL |
| Gentamicin Injection, USP | REMEDYREPACK INC. | 2024-10-10 | HUMAN PRESCRIPTION DRUG LABEL |
| GENTAMICIN - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-30 | HUMAN PRESCRIPTION DRUG LABEL |
| Gentamicin - Medical Purchasing Solutions, LLC | Medical Purchasing Solutions, LLC | 2023-11-10 | HUMAN PRESCRIPTION DRUG LABEL |
| Gentamicin - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2023-10-31 | HUMAN PRESCRIPTION DRUG LABEL |
| Gentamicin - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2023-10-20 | HUMAN PRESCRIPTION DRUG LABEL |
| Gentamicin - General Injectables & Vaccines, Inc | General Injectables & Vaccines, Inc | 2022-12-22 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-010-01 | Gentamicin | 2 mL in 1 VIAL | INJECTION, SOLUTION | 2 | 7 | |
| 63323-010-02 | Gentamicin | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 7 | |
| 63323-010-03 | Gentamicin | 20 mL in 1 VIAL | INJECTION, SOLUTION | 20 | 7 | |
| 63323-010-20 | Gentamicin | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 7 | |
| 63323-010-41 | Gentamicin | 2 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 2 | 4 | |
| 63323-010-42 | Gentamicin | 20 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 20 | 4 | |
| 63323-010-94 | Gentamicin | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 4 | |
| 63323-010-95 | Gentamicin | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 4 | |
| 63323-010-96 | Gentamicin | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 3 | |
| 63323-010-96 | Gentamicin | 20 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 20 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-010 | GENTAMICIN (GENTAMICIN SULFATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC ] | 7 | Current NDC, Legacy NDC, 4 package rows | 20231215_a73a5453-c091-43fd-aae2-d992152363b1.zip |
| 63323-010 | GENTAMICIN (GENTAMICIN SULFATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC ] | 4 | Current NDC, Legacy NDC, 4 package rows | 20231219_0cce2238-28d3-4280-b520-ffc3067a2ffa.zip |
| 63323-010 | GENTAMICIN (GENTAMICIN SULFATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 3 | Current NDC, Legacy NDC, 2 package rows | 20241017_84f5c763-1cd3-4d85-9afb-934db8666fbf.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-010-01 | ML - Milliliter | 63323-010 | 8f7fbb9f-e4ee-4c24-9cbf-cf5bb8b1d5fa | 1 | 2021-11-09 |
| 63323-010-02 | ML - Milliliter | 63323-010 | 92538238-da65-4ed7-8897-630760fe2e7c | 1 | 2013-02-13 |
| 63323-010-03 | ML - Milliliter | 63323-010 | 19616f55-e7a5-4305-8fdd-aa5fe3efe73c | 1 | 2021-10-08 |
| 63323-010-20 | ML - Milliliter | 63323-010 | c14a0d40-777c-4160-864c-67db4bc4ef43 | 1 | 2013-02-13 |
| 63323-010-41 | ML - Milliliter | 63323-010 | 4a00898e-ee4d-42cf-ac5d-a838db4deae9 | 1 | 2021-11-09 |
| 63323-010-42 | ML - Milliliter | 63323-010 | 12f4a20a-beb2-4941-b432-2e768988c155 | 1 | 2021-11-09 |
| 63323-010-94 | ML - Milliliter | 63323-010 | 68aa80b2-bd39-4e78-ba34-50985d84379c | 1 | 2013-12-02 |
| 63323-010-95 | ML - Milliliter | 63323-010 | 2f852c4c-085f-4c84-ab61-7553ed9f830c | 1 | 2013-12-02 |
| 63323-010-96 | ML - Milliliter | 63323-010 | fc20bbf7-9d1b-4004-a475-7c44486c15dd | 1 | 2014-02-04 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Kollourion Eyesalve Eyewash | PURIFIED WATER 98.3% | Miracle Eye Pharmaceuticals | b56d2ab9-169b-b490-e053-2a95a90a80b3 | 2025-12-28 | Warnings | 059QF0KO0R |
| Sterile Water | WATER | ProPharma Distribution | 386a0a2f-4ff7-f128-e063-6294a90a7d4d | 2025-12-18 | Warnings, Adverse reactions | 059QF0KO0R |
| OP-P | EMOTIONAL HEALTH BOOSTER | Vitality Works, Inc. | a8b87a49-fc73-4494-8dc9-059bc5f82d42 | 2025-12-17 | Warnings | O40UQP6WCF |
| Slenderiix | WEIGHT MANAGEMENT FORMULA | Vitality Works | 398251ec-6834-4dda-abc6-f503632d1632 | 2025-12-17 | Warnings | O40UQP6WCF |
| Firstep Firstflush | EYEWASH | Encon Safety Products, Inc. | a44beb26-79ae-98bd-e053-2995a90a9b74 | 2025-12-09 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | beda35c3-9a8b-47ad-e053-2995a90a7b1b | 2025-11-24 | Warnings | 059QF0KO0R |
| Easy Care First Aid Eyewash | WATER | Tender Corporation | a070aac8-e6d2-ef10-e053-2a95a90aa5b1 | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | e07a064b-f680-405c-bbcd-24fac430951e | 2025-11-24 | Warnings | 059QF0KO0R |
| ULINE Eyewash | EYEWASH | Niagara Pharmaceuticals Inc. | 2d7f22d2-320b-6af1-e063-6294a90addc6 | 2025-11-24 | Warnings | 059QF0KO0R |
| Pur-Wash | EYEWASH | Niagara Pharmaceuticals, Inc. | 0d43b1c1-2699-37f1-e054-00144ff88e88 | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | 777e1559-786f-8d54-e053-2991aa0aa98d | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | 7289103a-5cbf-42f4-8848-e827149a43ca | 2025-11-24 | Warnings | 059QF0KO0R |
| Eyewash Additive Concentrate | WATER AND PROPYLENE GLYCOL | Haws Corporation | dd168403-398c-41ff-b1df-d93e4ff39de3 | 2025-11-20 | Warnings | 059QF0KO0R |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | fd823bef-c14c-4708-a18a-8aaa8470412f | 2025-11-18 | Warnings, Adverse reactions | 059QF0KO0R |
| Eyesaline Eyewash Concentrate | PURIFIED WATER | Honeywell Safety Products USA, Inc. | 3765c251-eb14-d60f-e063-6294a90a6a4d | 2025-11-12 | Warnings | 059QF0KO0R |
| Eyesaline Emergency Eyewash | PURIFIED WATER | Honeywell Safety Products USA, Inc. | 37f244fd-c02f-e66a-e063-6394a90aed81 | 2025-11-12 | Warnings | 059QF0KO0R |
| STERILE WATER | WATER | Henry Schein, Inc. | f4087143-9868-4308-b96c-43657ee8ec28 | 2025-11-07 | Warnings, Adverse reactions | 059QF0KO0R |
| Bacteriostatic Water | BACTERIOSTATIC WATER | ProPharma Distribution | 42c6938e-f747-ae13-e063-6294a90a59a3 | 2025-11-04 | Warnings, Adverse reactions | 059QF0KO0R |
| Sterile Water | WATER | ICU Medical Inc. | aab10f03-26ae-4dbc-a481-ef025e48b405 | 2025-11-02 | Warnings, Adverse reactions | 059QF0KO0R |
| Sterile Water | WATER | ICU Medical Inc. | e3484bc6-ed7f-43ef-9d49-c131a8dff2dd | 2025-11-02 | Warnings, Adverse reactions | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.